Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Duolip

Known as: Merckle brand of etofyllinclofibrate 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

etofylline clofibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
[Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
BACKGROUND Duolip forte (ethophyllinclofibrate) is a lipid lowering drug, the effect of which was not yet adequately verified in… Expand
Is this relevant?
1994
1994
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
BACKGROUND Insulin resistance and hypertriacylglycerolaemia are part of the X syndrome and are supposed to be interrelated. The… Expand
Is this relevant?
1993
1993
[Duolip Forte--experience during a 6-month period of administration].
Duolip forte (ethophylline clofibrate, tablets à 500 mg) produced by Merckle Austria was administered to 20 patients with… Expand
Is this relevant?
1993
1993
[Therapy with fibrates and vitamin D metabolism].
The authors investigated in 29 patients with familial hyperlipoproteinaemia the effect of fibrate treatment (Duolip forte… Expand
Is this relevant?
1986
1986
Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
1-(7-Theophyllinyl)-2-ethyl-[2-(p-chlorophenoxy)-isobutyrate] (etofylline clofibrate, theofibrate, Duolip) was shown to possess… Expand
Is this relevant?
1983
1983
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
  • R. Scherhag
  • Fortschritte der Medizin
  • 1983
    • Corpus ID: 39248578
During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In… Expand
Is this relevant?
1980
1980
Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
The biopharmaceutic criteria of Duolip and its active principle, 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2… Expand
Is this relevant?
1980
1980
[Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author…
Esters of phenoxyacetic acids and oxyalkyltheophyllines were prepared as potential antihyperlipaemics. The basic idea was to… Expand
Is this relevant?
1980
1980
[On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Efficacy and tolerance of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, Duolip… Expand
Is this relevant?
1980
1980
[Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Efficacy of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML 1024, Duolip) and… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE